The adenovirus-2 E1B-55K protein interacts with a mSin3A/histone deacetylase 1 complex

被引:33
|
作者
Punga, T [1 ]
Akusjärvi, G [1 ]
机构
[1] Uppsala Univ, BMC, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden
来源
FEBS LETTERS | 2000年 / 476卷 / 03期
关键词
adenovirus; E1B-55K; histone deacetylase 1; mSin3A;
D O I
10.1016/S0014-5793(00)01739-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adenovirus E1B-55K protein is a multifunctional phosphoprotein that regulates nuclear to cytoplasmic export of host cell and viral mRNAs during lytic viral growth. E1B-55K also blocks apoptosis by binding and functionally inactivating the human tumor suppressor protein p53. Here, rye show that E1B-55K interacts with histone deacetylase 1 (HDAC1) and the transcriptional corepressor protein;mSin3A, both in the adenovirus-transformed 293 cell line and during a lytic adenovirus infection, Furthermore, we show that the central amino acids 156-261 in E1B-55K are necessary for efficient HDAC1 interaction. Importantly, the E1B-55K/mSin3A/DAC1 complex is also enzymatically active, catalyzing deacetylation of a histone substrate peptide, Collectively, our results suggest that E1B-55K interaction with mSin3A/HDAC1 containing complexes may be significant for one or several of the multiple activities ascribed to this protein. (C) 2000 Federation of European Biochemical Societies, Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:248 / 252
页数:5
相关论文
共 27 条
  • [11] Target gene therapy for α-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus
    Ohashi, M
    Kanai, F
    Tateishi, K
    Taniguchi, H
    Marignani, PA
    Yoshida, Y
    Shiratori, Y
    Hamada, H
    Omata, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (02) : 529 - 535
  • [12] Comparison of protein expression during wild-type, and E1B-55k-deletion, adenovirus infection using quantitative time-course proteomics
    Fu, Yen Rong
    Turnell, Andrew S.
    Davis, Simon
    Heesom, Kate J.
    Evans, Vanessa C.
    Matthews, David A.
    JOURNAL OF GENERAL VIROLOGY, 2017, 98 (06): : 1377 - 1388
  • [13] Disruption of NBS1/MRN Complex Formation by E4orf3 Supports NF-κB That Licenses E1B55K-Deleted Adenovirus-Infected Cells to Accumulate DNA>4n
    Almuzaini, Nujud
    Moore, Madison
    Robert-Guroff, Marjorie
    Thomas, Michael A.
    MICROBIOLOGY SPECTRUM, 2022, 10 (01):
  • [14] Assessment of a capsid-modified E1B 55-kDa protein-deficient adenovirus vector for tumor treatment
    Ye, X
    Lu, Q
    Zhao, Y
    Ren, Z
    Meng, X
    Ge, SF
    Qiu, QH
    Tong, Y
    Lieber, A
    Liang, M
    Hu, F
    Chen, HZ
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2005, 32 (12) : 1156 - 1164
  • [15] Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism, involving a Cullin-containing complex
    Querido, E
    Blanchette, P
    Yan, Q
    Kamura, T
    Morrison, M
    Boivin, D
    Kaelin, WG
    Conaway, RC
    Conaway, JW
    Branton, PE
    GENES & DEVELOPMENT, 2001, 15 (23) : 3104 - 3117
  • [16] The Promotion of Genomic Instability in Human Fibroblasts by Adenovirus 12 Early Region 1B 55K Protein in the Absence of Viral Infection
    Abualfaraj, Tareq
    Hagkarim, Nafiseh Chalabi
    Hollingworth, Robert
    Grange, Laura
    Jhujh, Satpal
    Stewart, Grant S.
    Grand, Roger J.
    VIRUSES-BASEL, 2021, 13 (12):
  • [17] E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells
    Shyamala Maheswaran
    Christoph Englert
    Sean Bong Lee
    Robert M Ezzel
    Jeffrey Settleman
    Daniel A Haber
    Oncogene, 1998, 16 : 2041 - 2050
  • [18] E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells
    Maheswaran, S
    Englert, C
    Lee, SB
    Ezzel, RM
    Settleman, J
    Haber, DA
    ONCOGENE, 1998, 16 (16) : 2041 - 2050
  • [19] Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins
    Hu, BL
    Zhu, HB
    Qiu, SB
    Su, Y
    Ling, WF
    Xiao, W
    Qi, YP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 325 (04) : 1153 - 1162
  • [20] Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector
    M-J Chen
    N K Green
    G M Reynolds
    J R Flavell
    V Mautner
    D J Kerr
    L S Young
    P F Searle
    Gene Therapy, 2004, 11 : 1126 - 1136